Drug Shortage Report for AURO-ALENDRONATE
Report ID | 131951 |
Drug Identification Number | 02388553 |
Brand name | AURO-ALENDRONATE |
Common or Proper name | ALENDRONATE |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ALENDRONIC ACID |
Strength(s) | 70MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1x4's |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-01-18 |
Estimated end date | 2021-04-30 |
Actual end date | 2021-04-20 |
Shortage status | Resolved |
Updated date | 2021-04-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-04-30 | French | Compare |
v7 | 2021-04-30 | English | Compare |
v6 | 2021-03-10 | French | Compare |
v5 | 2021-03-10 | English | Compare |
v4 | 2021-02-22 | French | Compare |
v3 | 2021-02-22 | English | Compare |
v2 | 2021-01-19 | French | Compare |
v1 | 2021-01-19 | English | Compare |
Showing 1 to 8 of 8